Abstract
The synthesis of new cephalosporin antibiotics has provided agents which can effectively be used to treat most of the different forms of meningitis. None of the first generation cephalosporins can be considered acceptable as agents to treat meningitis. Cefuroxime can be used to treat meningitis due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis in children. Agents such as cefotaxime and ceftriaxone are appropriate for neonatal meningitis due to Escherichia coli and group B streptococci, but not Listeria monocytogenes. Cefotaxime, ceftriaxone, ceftizoxime and ceftazidime have all proved effective as therapy of meningitis in children and adults when the pathogens are pneumococci, H. influenzae or N. meningitidis, but they have not been shown to yield an improved mortality or lower morbidity in spite of much greater cerebrospinal fluid (CSF) bactericidal titres. Cefotaxime, ceftizoxime, ceftriaxone and ceftazidime have been effective as therapy of meningitis due to E. coli, K. pneumoniae and Proteus species, but failures have occurred with all of the cephalosporins when used to treat meningitis due to Enterobacter spp. and Serratia marcescens. Only ceftazidime yields adequate CSF concentrations to t...Continue Reading
Citations
May 1, 1990·Journal of Clinical Pharmacology·H C Neu
Jul 13, 2011·Journal of Fluorescence·Jasmin ShahM Naeem
Apr 17, 2001·The Pediatric Infectious Disease Journal·X Sáez-Llorens, M O'Ryan
Jan 1, 1996·Fundamental & Clinical Pharmacology·A RadouaneB Bannwarth
May 1, 1992·Antimicrobial Agents and Chemotherapy·J P Bryan, W M Scheld
Feb 1, 1995·European Journal of Pediatrics·R F KornelisseH J Neijens
Jan 1, 1991·Infection·H C Neu
Apr 9, 1990·The American Journal of Medicine·H C Neu
Oct 1, 1989·American Journal of Infection Control·H C Neu
Mar 11, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wei ZhaoQuanmin Li
Apr 9, 1990·The American Journal of Medicine·R G Finch
Jun 19, 2004·Journal of Enzyme Inhibition and Medicinal Chemistry·Zahid H ChohanAndrea Scozzafava
Jul 1, 1993·The Annals of Pharmacotherapy·S L Preston, L L Briceland